22nd Century Pre-Tax Profit Margin 2011-2024 | XXII
22nd Century pre-tax profit margin from 2011 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| 22nd Century Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2024-09-30 |
$0.03B |
$-0.03B |
-122.22% |
| 2024-06-30 |
$0.03B |
$-0.04B |
-127.59% |
| 2024-03-31 |
$0.03B |
$-0.05B |
-168.97% |
| 2023-12-31 |
$0.03B |
$-0.06B |
-171.88% |
| 2023-09-30 |
$0.02B |
$-0.03B |
-143.48% |
| 2023-06-30 |
$0.03B |
$-0.04B |
-120.59% |
| 2023-03-31 |
$0.04B |
$-0.04B |
-95.00% |
| 2022-12-31 |
$0.04B |
$-0.04B |
-90.00% |
| 2022-09-30 |
$0.05B |
$-0.05B |
-100.00% |
| 2022-06-30 |
$0.04B |
$-0.04B |
-110.26% |
| 2022-03-31 |
$0.03B |
$-0.04B |
-109.09% |
| 2021-12-31 |
$0.03B |
$-0.03B |
-103.23% |
| 2021-09-30 |
$0.03B |
$-0.02B |
-80.00% |
| 2021-06-30 |
$0.03B |
$-0.02B |
-65.52% |
| 2021-03-31 |
$0.03B |
$-0.02B |
-74.07% |
| 2020-12-31 |
$0.03B |
$-0.02B |
-70.37% |
| 2020-09-30 |
$0.03B |
$-0.02B |
-70.37% |
| 2020-06-30 |
$0.03B |
$-0.03B |
-96.15% |
| 2020-03-31 |
$0.03B |
$-0.03B |
-107.69% |
| 2019-12-31 |
$0.03B |
$-0.03B |
-104.00% |
| 2019-09-30 |
$0.03B |
$-0.03B |
-116.00% |
| 2019-06-30 |
$0.03B |
$-0.01B |
-52.00% |
| 2019-03-31 |
$0.03B |
$-0.01B |
-46.15% |
| 2018-12-31 |
$0.03B |
$-0.01B |
-34.62% |
| 2018-09-30 |
$0.03B |
$-0.00B |
-16.00% |
| 2018-06-30 |
$0.02B |
$-0.01B |
-54.17% |
| 2018-03-31 |
$0.02B |
$-0.01B |
-42.86% |
| 2017-12-31 |
$0.02B |
$-0.01B |
-76.47% |
| 2017-09-30 |
$0.01B |
$-0.01B |
-85.71% |
| 2017-06-30 |
$0.01B |
$-0.01B |
-100.00% |
| 2017-03-31 |
$0.01B |
$-0.01B |
-109.09% |
| 2016-12-31 |
$0.01B |
$-0.01B |
-100.00% |
| 2016-09-30 |
$0.01B |
$-0.01B |
-100.00% |
| 2016-06-30 |
$0.01B |
$-0.01B |
-100.00% |
| 2016-03-31 |
$0.01B |
$-0.01B |
-90.91% |
| 2015-12-31 |
$0.01B |
$-0.01B |
-122.22% |
| 2015-09-30 |
$0.01B |
$-0.01B |
-233.33% |
| 2015-06-30 |
$0.00B |
$-0.01B |
-466.67% |
| 2015-03-31 |
$0.00B |
$-0.02B |
-1500.00% |
| 2014-12-31 |
$0.00B |
$-0.02B |
inf% |
| 2014-09-30 |
$0.01B |
$-0.02B |
-257.14% |
| 2014-06-30 |
$0.01B |
$-0.03B |
-428.57% |
| 2013-09-30 |
$0.00B |
$-0.02B |
inf% |
| 2012-09-30 |
$0.00B |
$-0.00B |
inf% |
| 2011-12-31 |
$0.00B |
$-0.00B |
-100.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.005B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
